Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neihulizumab in active psoriatic arthritis
NCT02267642Phase 2Completed
- Sponsor
- AbGenomics
- Start
- Jan 2015
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of neihulizumab in psoriatic arthritis (PsA), sponsored by AbGenomics. Started Jan 2015; status: completed.
02
Drugs
neihulizumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT02267642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02267642.